NEW YORK, May 26, 2015 (GLOBE NEWSWIRE) -- Cortice Biosciences, a clinical-stage drug development company pioneering novel therapies for oncologic and neurologic disease indications with urgent medical need, announced upcoming presentations at the following conferences:
Jefferies 2015 Global Healthcare Conference in New York, NY
Thursday, June 4 at 12:30 PM
BIO International Convention in Philadelphia, PA
Tuesday, June 16 at 2:45 PM
About Cortice Biosciences
Cortice Biosciences, Inc. is a clinical-stage drug development company pioneering novel therapies for oncologic and neurologic disease indications with urgent medical need. Lead compounds include TPI 287, a microtubule stabilizing agent in development for treatment of brain cancers and neurodegenerative tauopathies, and CRT 001, a noradrenergic receptor modulator in development for treatment of CNS diseases associated with cognitive impairment. More information can be found at www.corticebiosciences.com.